Browse by Medical Category
Go To Programs
A panel of experts convened by the Alzheimer's Association and the Society of Nuclear Medicine and Molecular Imaging have issued new guidelines on the use of amyloid PET imaging in diagnosing Alzheimer's disease.
Researchers using two brain-imaging technologies have found that apparently normal older individuals with brain deposits of amyloid beta – the primary constituent of the plaques found in the brains of Alzheimer's disease patients – also had changes in brain structure similar to those seen in Alzheimer's patients.
Back to Top